Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 3, 2013, Pages 679-685

  Khor, Richard ^a   Duchesne, Gillian ^a,b   Tai, Keen Hun ^a   Foroudi, Farshad ^a   Chander, Sarat ^a   Van Dyk, Sylvia ^a   Garth, Margaret ^a   Williams, Scott ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOHAZARDS; DISEASES; ONCOLOGY; PATIENT MONITORING; UROLOGY;

ANDROGEN DEPRIVATION THERAPY; EXTERNAL BEAM RADIATION THERAPY; FREEDOM FROM BIOCHEMICAL FAILURES; HIGH-DOSE RATE BRACHYTHERAPY; HIGH-RISK PROSTATE CANCERS; METHODS AND MATERIALS; PROGNOSTIC INDICATORS; PROPENSITY SCORE MATCHING;

RADIOTHERAPY;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; BIOCHEMICAL FAILURE FREE SURVIVAL; BRACHYTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CHEMICAL ANALYSIS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; TREATMENT DURATION; TREATMENT INDICATION; URETHRA STRICTURE;

EID: 84873284058     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.07.006     Document Type: Article

References (20)

1. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 2005 1233 1239
2. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
3. C. Proust-Lima, J.M. Taylor, and S. Secher Confirmation of a low alpha/beta ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics Int J Radiat Oncol Biol Phys 79 2011 195 201
4. J.R. Sathya, I.R. Davis, and J.A. Julian Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 2005 1192 1199
5. P.J. Hoskin, A.M. Rojas, and P.J. Bownes Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer Radiother Oncol 103 2012 217 222
6. J. Mohler, R.J. Babaian, and R.R. Bahnson Prostate cancer. Clinical practice guidelines in oncology J Natl Compr Canc Netw 5 2007 650 683
7. L. Sullivan, S.G. Williams, and K.H. Tai Urethral stricture following high dose rate brachytherapy for prostate cancer Radiother Oncol 91 2009 232 236
8. Bang D, Piccirillo J, Littenberg B, et al. The Adult Comorbidity Evaluation-27 (ACE-27) Testda new comorbidity index for patients with cancer. J Clin Oncol 19 (suppl):59s, abstr 1701
9. P. Diez, I.S. Vogelius, and S.M. Bentzen A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer Int J Radiat Oncol Biol Phys 77 2010 1066 1071
10. S. Williams, T. Pickles, and L. Kestin A multicenter study demonstrating discordant results from electronic prostate-specific antigen biochemical failure calculation systems Int J Radiat Oncol Biol Phys 65 2006 1494 1500
11. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346
12. B.B. Hansen, and S.O. Klopfer Optimal full matching and related designs via network flows J Comput Graph Stat 15 2006 609 627
13. D.F. McCaffrey, G. Ridgeway, and A.R. Morral Propensity score estimation with boosted regression for evaluating causal effects in observational studies Psychol Methods 9 2004 403 425
14. J. Tang, S. Williams, and K. Tai A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: evidence of hypofractionation efficacy? Brachytherapy 5 2006 256 261
15. L.L. Kestin, A.A. Martinez, and J.S. Stromberg Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer J Clin Oncol 18 2000 2869 2880
16. I. Deutsch, M.J. Zelefsky, and Z. Zhang Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT Brachytherapy 9 2010 313 318
17. J. Fowler, R. Chappell, and M. Ritter Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
18. A.A. Martinez, J. Gonzalez, and H. Ye Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy Int J Radiat Oncol Biol Phys 79 2011 363 370
19. N.N. Stone, L. Potters, and B.J. Davis Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 73 2009 341 346
20. R.M. Galalae, A. Martinez, and N. Nuernberg Hypofractionated conformal HDR brachytherapy in hormone naive men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups? Strahlenther Onkol 182 2006 135 141